Thomas Weichhart
- Immunology top 1%
- Mast cells and histamine 11
- Immune Cell Function and Interaction 9
- Immune cells in cancer 7
- T-cell and B-cell Immunology 7
- Aging top 2%
- Transplantation top 2%
- Nephrology top 2%
- Physiology top 2%
- Sarcoidosis and Beryllium Toxicity Research 9
-
- PI3K/AKT/mTOR signaling in cancer 18
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 9
-
- Cytokine Signaling Pathways and Interactions 8
- Co-authors
- Marcus D. SäemannMarkus HengstschlägerMonika LinkeWalter H. HörlNyamdelger SukhbaatarMaximilian ZeydaMichael HaidingerThomas M. Stulnig
- Cited by
- ImmunologyAgingTransplantation
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Thomas Weichhart
82 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Immunology 2.1k
- Aging 141
- Transplantation 198
- Nephrology 376
- Physiology 883
Countries citing papers authored by Thomas Weichhart
This map shows the geographic impact of Thomas Weichhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Weichhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Weichhart more than expected).
Fields of papers citing papers by Thomas Weichhart
This network shows the impact of papers produced by Thomas Weichhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Weichhart. The network helps show where Thomas Weichhart may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Weichhart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 38 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 7 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 67 | |
| 9 | 2021 | 11 | |
| 10 | 2017 | 47 | |
| 11 | 2016 | 97 | |
| 12 | 2016 | 88 | |
| 13 | Regulation of innate immune cell function by mTORbreakdown → | 2015 | 622 |
| 14 | 2014 | 13 | |
| 15 | 2014 | 48 | |
| 16 | 2013 | 15 | |
| 17 | 2010 | 16 | |
| 18 | 2010 | 77 | |
| 19 | 2007 | 111 | |
| 20 | 2005 | 23 |
About Thomas Weichhart
Thomas Weichhart is a scholar working on Immunology, Nephrology and Physiology, having authored 83 papers that have together received 5.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (18 papers), Mast cells and histamine (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers), Immune Cell Function and Interaction (9 papers), Cytokine Signaling Pathways and Interactions (8 papers), Immune cells in cancer (7 papers) and T-cell and B-cell Immunology (7 papers). The work is most often cited by research in Immunology (2.1k citations), Aging (141 citations) and Transplantation (198 citations). Thomas Weichhart has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Marcus D. Säemann, Markus Hengstschläger, Monika Linke, Walter H. Hörl, Nyamdelger Sukhbaatar, Maximilian Zeyda, Michael Haidinger, Thomas M. Stulnig, Marko Poglitsch and Gerhard J. Zlabinger. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.